BIRC’s response to the Coronavirus Outbreak Update #2 3-7-20

RESPIRATORY VIRAL ILLNESS (Including Covid‐19/Influenza) BIRC GUIDELINES  

Because many individuals from UConn and the surrounding communities utilize BIRC facilities, we are providing guidance on entering BIRC facilities and running participants. Also, please report a respiratory viral illness (Covid-19 or influenza) diagnosis to the Director of BIRC if you have been in the BIRC facilities within 14 days prior to the diagnosis.

Symptoms:<
FEVER (Temp >38°C/100.4°F), no other symptoms
Guidelines:
Stay at home. Investigators and participants may participate in BIRC research activities only when there has been at least 24 hours of no fever without the use of antipyretics (i.e., fever‐ reducing medications, such as Tylenol®, Motrin®, etc.)

Symptoms:
FEVER (Temp >38°C/100.4°F) WITH THESE SYMPTOMS: Cough, Sore throat, Nasal Congestion / Runny Nose, Myalgia (body aches)
Guidelines:
Stay at home. Investigators and participants may participate in BIRC research activities only when there has been at least 24 hours of no fever without the use of antipyretics (i.e., fever‐ reducing medications, such as Tylenol®, Motrin®, etc.) AND symptoms have significantly improved

Symptoms:
NO FEVER BUT WITH ONE OR MORE OF THESE SYMPTOMS: Cough, Sore throat, Nasal Congestion / Runny Nose, Myalgia (body aches)
Guidelines:
You may enter BIRC facilities but please avoid close-contact research activities such as EEG/TMS,  and avoid being in closed areas with another investigator or participant for a prolonged period of time (e.g. psychological testing in a testing room) UNTIL 24 hours have passed since the start of symptoms AND symptoms have significantly improved